EDITORIAL BOARD MEMBER - Michael Danquah
Michael Danquah is an Assistant Professor of Pharmaceutical Sciences at Chicago State University College of Pharmacy (CSU-COP). He obtained his Masters Degree in Chemical Engineering from the University of Kentucky, and a Ph.D. in Pharmaceutics and Drug Delivery from the University of Tennessee Health Science Center. He has expertise in pharmaceutical dosage forms and translational medicine and has several years experience in design and synthesis of novel biodegradable polymers for controlled drug and nucleic acid delivery, nano-based combination therapy for treating cancer, design and construction of novel bipartite shRNA expressing plasmids for cancer therapy, formulation, delivery, in vitro and in vivo characterization of siRNA,shRNA and miRNAs for treating cancer and application of stem cells and biomaterials for tissue regeneration and repair. Dr. Danquah also serves on the editorial board and as a regular reviewer for several journals. He is a member of many professional organizations including the American Association of Pharmaceutical Scientists (AAPS), American Chemical Society (ACS), American Association for Cancer Research (AACR), American Association of Colleges of Pharmacy (AACP), and the Society for Biomaterials (SFB). He
has several peer-reviewed journal articles and is the author of the book Emerging Trends in Cell and Gene Therapy.